Form D · Pharmaceuticals
BIONOVO INC
Emeryville, CA · CIK 0001203957
Offering snapshot reported Jul 20, 2010 · SEC filing
- Reported sold
- $600K Offering amount: $15.6M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 6, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 20, 2010 | Initial | $600,000 | No comparison | 1 | SEC filing |
| Mar 8, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 20, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-145238
The amount sold represents the value of the amount of common stock issued to the investor for payment of the commitment fee payable by the Issuer pursuant to the terms of the subject financing.
Source: Form D, filed Jul 20, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Baxter | Director |
| George Butler | Director |
| Thomas C. Chesterman | Executive |
| Isaac Cohen | Director, Executive |
| Louis Drapeau | Director |
| Mary Tagliaferri | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
5858 Horton Street Suite 400
Emeryville, CA, 94608
Emeryville, CA, 94608